Issue 10/2014
Content (8 Articles)
Bevacizumab Increases the Risk of Severe Congestive Heart Failure in Cancer Patients: An Up-to-Date Meta-Analysis with a Focus on Different Subgroups
Wei-Xiang Qi, Shen Fu, Qing Zhang, Xiao-Mao Guo
Evaluation of the Potential for a Pharmacokinetic Drug–Drug Interaction Between Armodafinil and Ziprasidone in Healthy Adults
Mona Darwish, Mary Bond, Ronghua Yang, Edward T. Hellriegel, Philmore Robertson Jr.
Triple Combination Therapy in Hypertension: The Antihypertensive Efficacy of Treatment with Perindopril, Amlodipine, and Indapamide SR
Dénes Páll, Ildikó Szántó, Zoltán Szabó
Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium
Thitima Kongnakorn, Tereza Lanitis, Lievens Annemans, Vincent Thijs, Sophie Marbaix
Evaluation of the Effect of Multiple Doses of Lansoprazole on the Pharmacokinetics and Safety of Ponatinib in Healthy Subjects
Narayana I. Narasimhan, David J. Dorer, Jeffrey Davis, Christopher D. Turner, Daryl Sonnichsen
Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari, Manabu Ishii, Masaki Sakai, Hideki Kuki, Kenichi Furihata
Population Pharmacokinetics and Dose–Exposure Proportionality of Edoxaban in Healthy Volunteers
Ophelia Q. P. Yin, Raymond Miller
Erratum to: Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium
Thitima Kongnakorn, Tereza Lanitis, Lieven Annemans, Vincent Thijs, Sophie Marbaix